Memphasys Ltd (MEM)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Memphasys Ltd (MEM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010970
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a bio-separations company that develops and commercializes separation techniques based on its membrane technology. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen sample using electrophoresis and specialist membranes for the use in fertility treatments, including IVF for humans, artificial reproductive techniques for animals; and hydrogel membranes. It caters to therapeutic plasma, IVF clinical, and research consumables markets. Memphasys also develops polymer membrane separation technology using polyacrylamide hydrogel membranes with electrophoresis. The company has operations in Australia, Singapore and the US. Memphasys is headquartered in Sydney, New South Wales, Australia.

Memphasys Ltd (MEM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Memphasys Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Memphasys Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Memphasys Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Memphasys Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Memphasys Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Memphasys Ltd, Medical Equipment, Deal Details 10
Equity Offering 10
Memphasys Prices USD0.5 Million in Rights Offering of Shares 10
Memphasys Plans to Raise USD0.9 Million in Private Placement of Shares 11
Memphasys Raises Funds in Public Offering of Shares 12
NuSep to Raise USD2 Million in Rights Offering of Shares 13
NuSep to Raise Funds through Share Purchase Plan 14
NuSep Completes Private Placement Of Shares For US$1 Million 15
NuSep Completes Rights Offering Of Shares For US$1.7 Million 16
NuSep Completes Public Offering Of Common Stock For US$1.9 Million 17
NuSep Completes Private Placement For US$0.99 Million 19
Debt Offering 21
Memphasys Plans to Raise USD0.2 Million in Public Offering of Notes Due 2017 21
Asset Transactions 22
Premier Biosoft Acquires ProteoIQ Business From NuSep 22
Memphasys Ltd – Key Competitors 23
Memphasys Ltd – Key Employees 24
Memphasys Ltd – Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Memphasys Ltd, Medical Equipment, Key Facts, 2017 2
Memphasys Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Memphasys Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Memphasys Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Memphasys Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Memphasys Ltd, Deals By Market, 2011 to YTD 2017 8
Memphasys Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Memphasys Prices USD0.5 Million in Rights Offering of Shares 10
Memphasys Plans to Raise USD0.9 Million in Private Placement of Shares 11
Memphasys Raises Funds in Public Offering of Shares 12
NuSep to Raise USD2 Million in Rights Offering of Shares 13
NuSep to Raise Funds through Share Purchase Plan 14
NuSep Completes Private Placement Of Shares For US$1 Million 15
NuSep Completes Rights Offering Of Shares For US$1.7 Million 16
NuSep Completes Public Offering Of Common Stock For US$1.9 Million 17
NuSep Completes Private Placement For US$0.99 Million 19
Memphasys Plans to Raise USD0.2 Million in Public Offering of Notes Due 2017 21
Premier Biosoft Acquires ProteoIQ Business From NuSep 22
Memphasys Ltd, Key Competitors 23
Memphasys Ltd, Key Employees 24

★海外企業調査レポート[Memphasys Ltd (MEM)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cape plc:企業の戦略・SWOT・財務情報
    Cape plc - Strategy, SWOT and Corporate Finance Report Summary Cape plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Cynosure Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cynosure Inc (Cynosure), a subsidiary of Hologic Inc, is a developer, manufacturer and supplier of light-based aesthetic and medical treatment systems. Its products facilitate non-invasive body contouring, skin revitalization and scar reduction, cellulite reduction, hair removal, gynecologic …
  • Newfoundland and Labrador Hydro:企業の戦略的SWOT分析
    Newfoundland and Labrador Hydro - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Med BioGene Inc (MBI)-医療機器分野:企業M&A・提携分析
    Summary Med BioGene Inc (Med BioGene) is a life sciences company, which develops and commercializes genome-based clinical laboratory diagnostic tests. The company’s lead test under development, GeneFx Lung formerly LungExpress Dx, is a proprietary gene expression based test. Its GeneFx Lung test is …
  • Coca-Cola FEMSA SAB de CV:戦略・SWOT・企業財務分析
    Coca-Cola FEMSA SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola FEMSA SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Hologic Inc (HOLX):医療機器:M&Aディール及び事業提携情報
    Summary Hologic Inc (Hologic) develops, manufactures and supplies diagnostic products, medical imaging systems, surgical products and light-based aesthetic and medical treatment systems. The company offers products to aid in the diagnosis of human diseases; breast imaging and related products and ac …
  • C3J Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary C3J Therapeutics Inc (C3J), formerly C3 Jian Inc, is a clinical-stage biotechnology company which concentrates on the development and commercialization of targeted and pathogen specific, antimicrobials that treat and prevent diseases caused by microbial dysbiosis. Its pipeline product portfo …
  • Baldwin & Lyons Inc:企業の戦略・SWOT・財務情報
    Baldwin & Lyons Inc - Strategy, SWOT and Corporate Finance Report Summary Baldwin & Lyons Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • China Synthetic Rubber Corp (2104):企業の財務・戦略的SWOT分析
    China Synthetic Rubber Corp (2104) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Firstsource Solutions Ltd (FSL):企業の財務・戦略的SWOT分析
    Firstsource Solutions Ltd (FSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Essar Power Limited-エネルギー分野:企業M&A・提携分析
    Summary Essar Power Limited (Essar Power), a subsidiary of Essar Energy Limited, is a power utility which produces electricity and thermal energy. It generates power from coal, natural gas, and co-generation plants. The company owns and operates power generation plants in India and Canada. Through i …
  • SKF AB:企業の戦略・SWOT・財務分析
    SKF AB - Strategy, SWOT and Corporate Finance Report Summary SKF AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Crown Bioscience Inc (6554):製薬・医療:M&Aディール及び事業提携情報
    Summary Crown Bioscience Inc (Crown Bioscience) is a drug discovery company that provides drug discovery and development services. The company offers antibodies, proteins, cell lines, tumor samples, in vivo and in vitro research reagents. It offers services such as preclinical research services, onc …
  • The Home Depot, Inc.:企業の戦略・SWOT・財務情報
    The Home Depot, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Home Depot, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hudson’s Bay Company (HBC):企業の財務・戦略的SWOT分析
    Hudson's Bay Company (HBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Tallink Grupp AS:企業の戦略・SWOT・財務情報
    Tallink Grupp AS - Strategy, SWOT and Corporate Finance Report Summary Tallink Grupp AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bank of China Ltd:企業のM&A・事業提携・投資動向
    Bank of China Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of China Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Moody’s Corporation:企業のM&A・事業提携・投資動向
    Moody's Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Moody's Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Globus Medical Inc (GMED):企業の財務・戦略的SWOT分析
    Globus Medical Inc (GMED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Greentech Energy Systems AS (GES)-エネルギー分野:企業M&A・提携分析
    Summary Greentech Energy Systems AS (Greentech) is an energy company which operates renewable energy plants. It generates electricity from wind and solar sources. Through long-term power purchase agreements, the company sells electricity. Greentech expands its asset portfolio through inorganic growt …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆